1-3 of 3
Mehmet Sinan Dal
Close
Save search
Sort by
Journal Articles

Real-Life Use of Asciminib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Results of the Turkish Managed Access Program

Free
Deniz Özmen, Derya Deniz Kürekçi, Vildan Özkocaman, Burcu Altındağ Avcı, Denis Sabriye Bozer, Mutlu Kasar, Osman Şahin, Gülten Korkmaz Akat, Ferda Can, Mehmet Sezgin Pepeler, Nergiz Erkut, Onur Kırkızlar, Kübra Yel Uygun, Tuba Bulduk, Murat Yıldırım, Müzeyyen Aslaner Ak, Şermin Altındal, Fatma Arıkan, Mehmet Sinan Dal, Burak Deveci, Nil Güler, Ahmet Kürşad Güneş, Emel Gürkan, Demircan Özbalcı, Osman Can Öztürk, Burcu Ülküden, Hüseyin Yılmaz, Meltem Kurt Yüksel, Meltem Aylı, Ahmet Muzaffer Demir, Düzgün Özatlı, Fahir Özkalemkaş, Güray Saydam, Mehmet Sönmez, Burhan Turgut, Mehmet Turgut, Ali Ünal, Ahmet Emre Eskazan
Journal: Blood
Blood (2024) 144 (Supplement 1): 6588.
https://doi.org/10.1182/blood-2024-202019
Published: 2024
Journal Articles

Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma: Real World Data

Free
Burhan Ferhanoglu, Zafer Gulbas, Ant Uzay, Muhit Özcan, Fahir Ozkalemkas, Mehmet Sinan Dal, Hakan Kalyon, Olga Meltem Akay, Burak Deveci, Huseyin Bekoz, Omur Gokmen Sevindik, Tayfur Toptas, Asu Fergun Yilmaz, Derya Koyun, Nihan Alkis, Elif Birtas Atesoglu
Journal: Blood
Blood (2022) 140 (Supplement 1): 6704–6705.
https://doi.org/10.1182/blood-2022-165385
Published: 2022
Journal Articles

Is It Time for Early Cessation of Empirical Antibiotherapy in Patients Presenting with Febrile Neutropenia? Preliminary Results of a Risk-Adapted Approach in a Hematology Clinic

Free
Ali Hakan Kaya, MD, Emre Tekgunduz, MD, Filiz Bekdemir, MD, Hikmetullah Batgi, MD, Tugcenur Yigenoglu, MD, Bahar Uncu Ulu, MD, Bilge Ugur, MD, Dicle Iskender, MD, Merih Kizil Cakar, MD, Mehmet Sinan Dal, MD, Seval Akpinar, MD, Fatih Demirkan, MD, Fevzi Altuntas, MD
Journal: Blood
Blood (2016) 128 (22): 2503.
https://doi.org/10.1182/blood.V128.22.2503.2503
Published: 2016